Hypopharyngeal cancer

Last updated
Hypopharyngeal cancer
HypopharynxCa.jpg
Specialty Oncology

Hypopharyngeal cancer is a disease in which malignant cells grow in the hypopharynx (also known as the laryngopharynx) the area where the larynx and esophagus meet. [1]

Contents

It first forms in the outer layer (epithelium) of the hypopharynx (last part of the pharynx), which is split into three areas. Progression of the disease is defined by the spread of cancer into one or more areas and into deeper tissues. [1]

This type of cancer is rare. Only about 2,500 cases are seen in the US each year. [2] Because of this, Hypopharyngeal Cancer is difficult to catch in its earliest stages and has one of the highest mortality rates of any head and neck cancer. [3]

Signs and symptoms

Symptoms of Hypopharyngeal Cancer include:

Cause

Factors that contribute to the development of hypopharyngeal cancer include:

Smoking, like lung cancer, can cause hypopharyngeal cancer because it contains carcinogens that alter the DNA or RNA in a dividing cell. These alterations may change a normal DNA sequence to an oncogene, a gene that causes cancer after exposure to a carcinogen.

Squamous cells, a type of cell that lines hollow organs like the throat, mouth, lungs, and outer layer of skin, are particularly vulnerable when exposed to cigarette smoke. [5]

Chewing tobacco can have the same effects as smoking and is also linked to hypopharyngeal cancer. The chewing tobacco is placed into the mouth, leaving it exposed to enzymes, like amylase, which partly digests the carcinogenic material. Saliva is swallowed, along with the cancer-promoting material, which passes through the hypopharynx on its way to the esophagus.

Heavy alcohol use is linked to hypopharyngeal cancer as well. Alcohol damages the lining of the hypopharynx, increasing the amount of chemicals that are allowed to seep into the underlying membranes. Heavy alcohol use is also associated with nutritional deficiencies. [1]

Laryngopharyngeal reflux is considered to be a risk factor for development of hypopharyngeal cancer. [6] Such reflux frequently contains bile acids, and bile acid presence in the upper aerodigestive tract is associated with inflammation, DNA damage and neoplastic changes. [6]

A disease called Plummer–Vinson syndrome, a genetic disorder that causes a long-term iron deficiency, may also lead to hypopharyngeal cancer. Other factors like a deficiency in certain vitamins also appear to contribute to this type of cancer. [1]

Diagnosis

Stages and survival rates

Staging cancer is a way of marking the cancer's progression and is measured on a 0 to 4 (IV) scale. To determine each stage, smaller categories must be defined first: T. N. M. (tumor, lymph nodes, and metastasis). These were developed by the American Joint Committee on Cancer. [3]

Early stage

Stages of Hypopharyngeal Cancer [3]
Tumor (T)Lymph Nodes (L)Metastasis (M)
Stage 0Epithelium OnlyNoneM0
Stage 1T1NoneM0
Stage 2T2NoneM0
Stage 3T1-T3

Or T3

N1

None

M0

M0

Stage 4 (A)T1-T3

Or T4

N2

N1-N2

M0

M0

Stage 4 (B)T4N1, N2 or N3M0
Stage 4 (C)T1-T4N1-N2M1

Stage 0

This implies that a tumor was found in the epithelium, the layer of tissue closest to the top, but not in the connective tissue. A patient would not have swollen lymph nodes and the cancer has not metastasized to other tissues or organs. This is almost never diagnosed in the case of Hypopharyngeal Cancer. [3]

Stage I (1)

T1: the tumor is less than 2 cm across and is limited to one area in the hypopharynx. There is still no lymph node involvement and no metastasis. [3]

Stage I Hypopharyngeal Cancer has a five-year survival rate of 41%, but this type of cancer is rarely caught in Stage I because the first signs and symptoms are often unnoticed or patients remain asymptomatic. [3]

Stage II (2)

T2: the tumor has grown to affect more than one area of the hypopharynx and is between 2 and 4 centimeters with no lymph node involvement and no metastasis. [3]

Late stage

Stage III (3)

T1 or T2 or T3: the tumor's growth is between less than 2 cm and more than 4 cm and may be affecting the vocal cords. AND N1: cancer has spread to one lymph node (same side of the neck as tumor), which has swollen to 3 cm or less. OR T3: the tumor is more than 4 cm and is affecting the vocal cords. BUT there is no lymph node involvement. [3]

Note: The distinction between the two is made by the oncologist.

Stage II and III have a five-year survival rate of 36%. [3]

Stage IV (4)

The final stage has three subsets depending on the severity of the cancer.

Stage IVA

T1 or T2 or T3: the tumor is between less than 2 cm or more than 4 cm.

AND N2: cancer has spread to one or more lymph nodes, less than 6 cm, on one or both sides of the neck.

OR

T4: the tumor is affecting different areas outside of the hypopharynx, starting with the throat and moving towards the spine and chest cavity.

AND N1 or N2: cancer is affecting 1 or more lymph nodes that are between less than 3 and less than 6 cm on one or both sides of the throat.

Stage IVB

T4: The tumor is affecting areas outside of the hypopharynx.

N1 or N2 or N3: Lymph nodes are between less than 3 or up to 6 cm on one or both sides of the neck.

Stage IVC (end stage)

The cancer could be anything from T1 to T4, N1 to N4, but the major difference is that the cancer has metastasized (M1) to other organs away from the hypopharynx.

Stage IV hypopharyneal cancer only has a 10% five-year survival. [3]

Most cases of hypopharyneal cancer are found in the end stage because the cancer is close to several large lymphatic vessels, easily spreading to other regions of the body. [7]

Tests to diagnose hypopharyngeal cancer

There are several ways to diagnose Hypopharyngeal Cancer.

The doctor checks for swollen lymph nodes and may look down the patient's throat with a long handled mirror. [1]

Inserted into the nose or mouth of the patient, this uses a thin fiberoptic camera that allows the doctor to see directly down the throat.

This is a small tissue sample taken from the lesion. The tissue is analyzed for the presences of cancer cells. [1]

These tests will give doctors a detailed cross-sectional image of the area in question in the body. It can confirm or suggest a diagnosis and also stage extent of disease. [1]

Management

Treatment of hypopharyngeal cancer depends on the prognosis (chance of recovery), age, stage, and general health of the patient. Because hypopharyngeal cancer is often advanced at the time of diagnosis, treatment also depends on the overall goal. The goal may simply be to keep the patient talking, eating, and breathing normally. [7]

Treatment usually begins with surgery and then a course of radiation for cancer that has progressed past Stage I. For cancer that is advanced, which is typical of hypopharyngeal cancer, neoadjuvant chemotherapy may be used. This is performed by administering chemotherapy before surgery. Neoadjuvant chemotherapy in conjunction with radiation and surgery has yielded the best results in patients with Stage III and Stage IV cancers. [7]

Related Research Articles

<span class="mw-page-title-main">Metastasis</span> Spread of a disease inside a body

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.

<span class="mw-page-title-main">Esophageal cancer</span> Gastrointestinal system cancer that is located in the esophagus

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach. Symptoms often include difficulty in swallowing and weight loss. Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.

Penile cancer, or penile carcinoma, is a cancer that develops in the skin or tissues of the penis. Symptoms may include abnormal growth, an ulcer or sore on the skin of the penis, and bleeding or foul smelling discharge.

<span class="mw-page-title-main">Laryngeal cancer</span> Medical condition

Laryngeal cancer or throat cancer is a kind of cancer that can develop in any part of the larynx. It is typically a squamous-cell carcinoma, reflecting its origin from the epithelium of the larynx.

The TNM Classification of Malignant Tumors (TNM) is a globally recognised standard for classifying the anatomical extent of the spread of malignant tumours (cancer). It has gained wide international acceptance for many solid tumor cancers, but is not applicable to leukaemia or tumors of the central nervous system. Most common tumors have their own TNM classification. The TNM staging system is sometimes referred to as the AJCC/UICC staging system or the UICC/AJCC staging system.

<span class="mw-page-title-main">Anal cancer</span> Medical condition

Anal cancer is a cancer which arises from the anus, the distal opening of the gastrointestinal tract. Symptoms may include bleeding from the anus or a lump near the anus. Other symptoms may include pain, itchiness, or discharge from the anus. A change in bowel movements may also occur.

<span class="mw-page-title-main">Head and neck cancer</span> Cancer arises in the head or neck region

Head and neck cancer develops from tissues in the lip and oral cavity (mouth), larynx (throat), salivary glands, nose, sinuses, or skin of the face. The most common types of head and neck cancer occur in the lips, mouth, and larynx. Symptoms predominantly include a sore that does not heal or a change in the voice. In those with advanced disease, there may be unusual bleeding, facial pain, numbness or swelling, and visible lumps on the outside of the neck or oral cavity. Given the location of these cancers, it is possible for an afflicted individual to experience difficulty in breathing.

<span class="mw-page-title-main">Pancoast tumor</span> Medical condition

A Pancoast tumor is a tumor of the apex of the lung. It is a type of lung cancer defined primarily by its location situated at the top end of either the right or left lung. It typically spreads to nearby tissues such as the ribs and vertebrae. Most Pancoast tumors are non-small-cell lung cancers.

Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach to treatment. Prostate cancer stage can be assessed by either clinical or pathological staging methods. Clinical staging usually occurs before the first treatment and tumour presence is determined through imaging and rectal examination, while pathological staging is done after treatment once a biopsy is performed or the prostate is removed by looking at the cell types within the sample.

<span class="mw-page-title-main">Papillary thyroid cancer</span> Medical condition

Papillary thyroid cancer is the most common type of thyroid cancer, representing 75 percent to 85 percent of all thyroid cancer cases. It occurs more frequently in women and presents in the 20–55 year age group. It is also the predominant cancer type in children with thyroid cancer, and in patients with thyroid cancer who have had previous radiation to the head and neck. It is often well-differentiated, slow-growing, and localized, although it can metastasize.

<span class="mw-page-title-main">Nasopharyngeal carcinoma</span> Type of throat cancer; most common to occur in the nasopharynx

Nasopharyngeal carcinoma (NPC), or nasopharynx cancer, is the most common cancer originating in the nasopharynx, most commonly in the postero-lateral nasopharynx or pharyngeal recess, accounting for 50% of cases. NPC occurs in children and adults. NPC differs significantly from other cancers of the head and neck in its occurrence, causes, clinical behavior, and treatment. It is vastly more common in certain regions of East Asia and Africa than elsewhere, with viral, dietary and genetic factors implicated in its causation. It is most common in males. It is a squamous cell carcinoma of an undifferentiated type. Squamous epithelial cells are a flat type of cell found in the skin and the membranes that line some body cavities. Undifferentiated cells are cells that do not have their mature features or functions.

Cancer of unknown primary origin (CUP) is a cancer that is determined to be at the metastatic stage at the time of diagnosis, but a primary tumor cannot be identified. A diagnosis of CUP requires a clinical picture consistent with metastatic disease and one or more biopsy results inconsistent with a tumor cancer

Lung cancer staging is the assessment of the extent to which a lung cancer has spread from its original source. As with most cancers, staging is an important determinant of treatment and prognosis. In general, more advanced stages of cancer are less amenable to treatment and have a worse prognosis.

Breast cancer classification divides breast cancer into categories according to different schemes criteria and serving a different purpose. The major categories are the histopathological type, the grade of the tumor, the stage of the tumor, and the expression of proteins and genes. As knowledge of cancer cell biology develops these classifications are updated.

<span class="mw-page-title-main">Spiradenoma</span> Medical condition

Spiradenomas (SA) are rare, benign cutaneous adnexal tumors that may progress to become their malignant counterparts, i.e. spiradenocarcinomas (SAC). Cutaneous adnexal tumors are a group of skin tumors consisting of tissues that have differentiated towards one of the four primary adnexal structures found in normal skin: hair follicles, sebaceous sweat glands, apocrine sweat glands, and eccrine sweat glands. SA and SAC tumors were regarded as eccrine gland tumors and termed eccrine spiradenomas and eccrine spiradenocarcinomas, respectively. However, more recent studies have found them to be hair follicle tumors and commonly term them spiradenomas and spiradenocarcinomas, respectively. Further confusing the situation, SA-like and SAC-like tumors are also 1) manifestations of the inherited disorder, CYLD cutaneous syndrome (CCS), and 2) have repeatedly been confused with an entirely different tumor, adenoid cystic carcinomas of the salivary gland. Here, SA and SAC are strictly defined as sporadic hair follicle tumors that do not include the hereditary CCS spiradenomas and heridtary spiradenocarcinoms of CCS or the adenoid cystic carcinomas.

<span class="mw-page-title-main">Microcystic adnexal carcinoma</span> Medical condition

Microcystic adnexal carcinoma (MAC) is a rare sweat gland cancer, which often appears as a yellow spot or bump in the skin. It usually occurs in the neck or head, although cases have been documented in other areas of the body. Most diagnosis occur past the age of 50. Although considered an invasive cancer, metastasis rarely occurs. If the tumor spreads, it can grow and invade fat, muscles, and other types of tissue. Main treatments are wide local excision or Mohs micrographic surgery, which ensures that most, if not all, cancer cells are removed surgically.

<span class="mw-page-title-main">HPV-positive oropharyngeal cancer</span> Cancer of the throat

Human papillomavirus-positive oropharyngeal cancer, is a cancer of the throat caused by the human papillomavirus type 16 virus (HPV16). In the past, cancer of the oropharynx (throat) was associated with the use of alcohol or tobacco or both, but the majority of cases are now associated with the HPV virus, acquired by having oral contact with the genitals of a person who has a genital HPV infection. Risk factors include having a large number of sexual partners, a history of oral-genital sex or anal–oral sex, having a female partner with a history of either an abnormal Pap smear or cervical dysplasia, having chronic periodontitis, and, among men, younger age at first intercourse and a history of genital warts. HPV-positive OPC is considered a separate disease from HPV-negative oropharyngeal cancer.

<span class="mw-page-title-main">Cervical lymphadenopathy</span> Disease of the lymph nodes

Cervical lymphadenopathy refers to lymphadenopathy of the cervical lymph nodes. The term lymphadenopathy strictly speaking refers to disease of the lymph nodes, though it is often used to describe the enlargement of the lymph nodes. Similarly, the term lymphadenitis refers to inflammation of a lymph node, but often it is used as a synonym of lymphadenopathy.

Colon cancer staging is an estimate of the amount of penetration of a particular cancer. It is performed for diagnostic and research purposes, and to determine the best method of treatment. The systems for staging colorectal cancers depend on the extent of local invasion, the degree of lymph node involvement and whether there is distant metastasis.

Carcinoma of the tonsil is a type of squamous cell carcinoma. The tonsil is the most common site of squamous cell carcinoma in the oropharynx. It comprises 23.1% of all malignancies of the oropharynx. The tumors frequently present at advanced stages, and around 70% of patients present with metastasis to the cervical lymph nodes. . The most reported complaints include sore throat, otalgia or dysphagia. Some patients may complain of feeling the presence of a lump in the throat. Approximately 20% patients present with a node in the neck as the only symptom.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 "General Information About Hypopharyngeal Cancer". National Cancer Institute. Archived from the original on 2009-09-25. Retrieved 2008-03-29.
  2. "Hypopharyngeal Cancer Treatment". WebMD. Archived from the original on 2012-02-20. Retrieved 2008-03-29.
  3. 1 2 3 4 5 6 7 8 9 10 "Detailed Guide: Laryngeal and Hypopharyngeal Cancer How Are Laryngeal and Hypopharyngeal Cancers Staged?". American Cancer Society. Archived from the original on 2020-04-26. Retrieved 2008-03-29.
  4. Quon, Harry; Goldenberg, David (2022-03-15). "Hypopharyngeal Cancer: Overview, Clinical Presentation, Etiology and Risk Factors" . eMedicine .
  5. Conrad Stöppler, Melissa, ed. (2021-03-29). "Medical Definition of Squamous cells". MedicineNet . Retrieved 2022-04-04.
  6. 1 2 Vageli, Dimitra P.; Doukas, Sotirios G.; Doukas, Panagiotis G.; Judson, Benjamin L. (November 2021). "Bile reflux and hypopharyngeal cancer (Review)". Oncology Reports. 46 (5): 244. doi:10.3892/or.2021.8195. PMC   8485019 . PMID   34558652.
  7. 1 2 3 "Hypopharyngeal Cancer Treatment (PDQ)". National Cancer Institute. Archived from the original on 2015-04-09. Retrieved 2008-03-29.